Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Turmoize Lotion is a topical dermatological moisturizer developed and marketed by La Pristine Bioceuticals. It is primarily indicated for the management of dry skin (xerosis) and as an adjunct in various skin conditions requiring barrier repair and antioxidant support. The formulation typically features **tetrahydrocurcumin**, a colorless, hydrogenated metabolite of curcumin known for its potent antioxidant and anti-inflammatory properties. Unlike traditional turmeric extracts, tetrahydrocurcumin does not stain the skin while effectively protecting against oxidative stress and reducing inflammatory responses. The lotion also incorporates emollients such as squalane to restore the skin's lipid barrier and improve overall hydration and texture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Turmoize Lotion.